Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Anders Ask"'
Autor:
Britta Lödén, Lars Franzén, E. Persson, Anders Ask, Hans Modig, Gun Wickart-Johansson, Ove Björ, Claes Mercke, Lena Wittgren, Helena Sjödin, Elisabeth Kjellén, Per Nilsson, Eva Brun, Signe Friesland, Freddi Lewin, Karl-Axel Johansson, Thomas Björk-Eriksson, Jan-Olof Fernberg, Björn Zackrisson, Lars Ekberg, Jan Nyman, Johan Reizenstein
Publikováno v:
Radiotherapy and Oncology. 100:41-48
Background and purpose: Studies on accelerated fractionation (AF) in head and neck cancer have shown increased local control and survival compared with conventional fractionation (CF), while others have been non-conclusive. In 1998 a national Swedish
Autor:
Lars Franzén, Anders Ask, Karin Söderström, Jan Nyman, Helena Sjödin, Erik Lundin, Karl-Axel Johansson, Gun Wickart-Johansson, Elisabeth Kjellén, Johan Wennerberg, Eva Brun, Signe Friesland, Britta Lödén, Freddi Lewin, Per Nilsson, Tina Dalianis, Lars Ekberg, Thomas Björk-Eriksson, Björn Zackrisson, Johan Reizenstein
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 117(1)
This report contains the mature five-year data from the Swedish ARTSCAN trial including information on the influence of p16 positivity (p16+) for oropharyngeal cancers.Patients with previously untreated squamous cell carcinoma without distant metasta
Autor:
Britta Lödén, Eva Hammerlid, Per Fransson, Karin Söderström, Lars Franzén, Erik Lundin, Anders Ask, Eva Brun, Per Nilsson, Signe Friesland, Johanna Nyqvist, Elisabeth Kjellén, Helena Sjödin, Göran Laurell, Johan Reizenstein, Freddi Lewin, Gun Wickart-Johansson, Thomas Björk-Eriksson, Lars Ekberg, Jan Nyman, Björn Zackrisson
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 118(2)
Health related quality of life (HRQoL) was assessed in the randomised, prospective ARTSCAN study comparing conventional radiotherapy (CF) with accelerated radiotherapy (AF) for head and neck cancer.750 patients with squamous cell carcinoma (of any gr
Autor:
M. Karlsson, Anders Ask, Thomas Björk-Eriksson, Bengt Johansson, Erik Blomquist, Göran Bjelkengren, Björn Zackrisson, Bengt Glimelius
Publikováno v:
Acta Oncologica. 44:836-849
A group of Swedish radiation oncologists and hospital physicists have estimated the number of patients in Sweden suitable for proton beam therapy in a facility where one of the principal aims is to facilitate randomized and other studies in which the
Publikováno v:
Acta Oncologica. 44:876-880
A group of Swedish oncologists and hospital physicists have estimated the number of patients in Sweden suitable for proton beam therapy. The estimations have been based on current statistics of tumour incidence, number of patients potentially eligibl
Autor:
Roland Andersson, Anders Ask, Gert Lindell, Sven-Börje Ewers, Ingemar Ihse, Karl-Göran Tranberg
Publikováno v:
Pancreatology. 5:438-442
Local recurrence is one of the most common sites of failure after resection of exocrine pancreatic adenocarcinoma. Intraoperative radiotherapy (IORT) involves delivery of high doses of irradiation to the pancreas in patients with locally advanced dis
Autor:
Ulrik Lassen, Henrik Schultz, Hans Skovgaard Poulsen, Anders Ask, Morten Sorensen, Junia Costa, Kirsten Grunnet, Carsten Thomsen, Kenneth Francis Hofland, Steinbjørn Hansen, Charlotte Kristiansen, Silke Engelholm, Aida Muhic
Publikováno v:
Hofland, K F, Hansen, S, Sorensen, M, Engelholm, S, Schultz, H P, Muhic, A, Grunnet, K, Ask, A, Costa, J C, Kristiansen, C, Thomsen, C, Poulsen, H S & Lassen, U 2014, ' Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study ', Acta Oncologica, vol. 53, no. 7, pp. 939-944 . https://doi.org/10.3109/0284186X.2013.879607
BACKGROUND: Surgery followed by radiotherapy and concomitant and adjuvant temozolomide is standard therapy in newly diagnosed glioblastoma multiforme (GBM). Bevacizumab combined with irinotecan produces impressive response rates in recurrent GBM. In
Publikováno v:
Urology. 50:747-753
Objectives In a prospective randomized Canadian trial, addition of radionuclide strontium ( 89 Sr) to external radiotherapy (ER) was found to prolong the time to further ER by 15 weeks (35 versus 20, P = 0.006) compared to ER alone in patients with h
Publikováno v:
Acta Oncologica. 44:918-920
A group of Swedish oncologists and hospital physicists have estimated the number of patients in Sweden suitable for proton beam therapy. The estimations have been based on current statistics of tumour incidence, number of patients potentially eligibl
Publikováno v:
Cancer Letters. 66:29-34
When L1210 leukemia cells are inhibited in their polyamine synthesis by treatment with alpha-difluoromethylornithine (DFMO), their growth in culture is strongly suppressed. In striking contrast, the survival of L1210 leukemic mice is only marginally